Loomis, Sayles & Company
INSP icon

Loomis, Sayles & Company’s Inspire Medical Systems INSP Stock Holding History

Loomis, Sayles & Company’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-199,969
Closed -$39.7M – 1003
2023
Q3 		$39.7M Sell
199,969
-51,824
-21% -$13.1M 0.07% 138
2023
Q2 		$81.7M Sell
251,793
-34,824
-12% -$9.95M 0.13% 74
2023
Q1 		$67.1M Buy
286,617
+2,264
+0.8% +$572K 0.12% 91
2022
Q4 		$71.6M Sell
284,353
-6,797
-2% -$1.45M 0.14% 80
2022
Q3 		$51.6M Sell
291,150
-3,577
-1% -$719K 0.1% 94
2022
Q2 		$53.8M Sell
294,727
-1,519
-0.5% -$303K 0.1% 94
2022
Q1 		$76M Sell
296,246
-5,708
-2% -$1.3M 0.1% 85
2021
Q4 		$69.5M Buy
301,954
+38,851
+15% +$9.49M 0.08% 105
2021
Q3 		$61.3M Sell
263,103
-4,065
-2% -$848K 0.08% 117
2021
Q2 		$51.6M Sell
267,168
-89,163
-25% -$17.7M 0.06% 141
2021
Q1 		$73.8M Sell
356,331
-37,085
-9% -$7.88M 0.1% 90
2020
Q4 		$74M Sell
393,416
-2,237
-0.6% -$366K 0.1% 86
2020
Q3 		$51.1M Buy
395,653
+7,463
+2% +$822K 0.07% 106
2020
Q2 		$33.8M Buy
388,190
+74,580
+24% +$5.73M 0.05% 142
2020
Q1 		$18.9M Buy
313,610
+39,819
+15% +$2.95M 0.04% 174
2019
Q4 		$20.3M Buy
+273,791
New +$17.6M 0.03% 209

Other funds holding INSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Loomis, Sayles & Company's INSP Position: Q4 2023 in Review

Loomis, Sayles & Company sold out of Inspire Medical Systems (INSP) in Q4 2023, closing a stake of 199,969 shares — an estimated $39.7M sold.

Loomis, Sayles & Company first reported a position in INSP in Q4 2019 and held it in 16 quarters. The position peaked at $81.7M in Q2 2023. 343 funds tracked by Wall St. Rank hold INSP as of Q4 2023.

  • Loomis, Sayles & Company reported no remaining Inspire Medical Systems position as of Q4 2023 after selling out during the quarter.
  • Loomis, Sayles & Company sold 199,969 Inspire Medical Systems shares in Q4 2023, an estimated $39.7M.
  • Loomis, Sayles & Company first reported a position in Inspire Medical Systems in Q4 2019 and held it in 16 quarters.
  • Loomis, Sayles & Company's Inspire Medical Systems position peaked at $81.7M in Q2 2023.
  • 343 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2023.

Based on Loomis, Sayles & Company's 13F filing for Q4 2023, filed 13 Feb 2024.